Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · IEX Real-Time Price · USD
8.86
+0.49 (5.85%)
At close: Jul 26, 2024, 4:00 PM
8.93
+0.07 (0.79%)
After-hours: Jul 26, 2024, 6:36 PM EDT
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $273.57 million as of July 26, 2024. Its market cap has increased by 2.12% in one year.
Market Cap
273.57M
Enterprise Value
167.62M
1-Year Change
2.12%
Ranking
Category
Stock Price
$8.86
Market Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has increased from $235.12M to $273.57M, an increase of 16.35%. That is a compound annual growth rate of 9.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 258.40M | 136.63% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.60M | 2.33% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Codexis | 251.19M |
| Nanobiotix | 251.10M |
| Sera Prognostics | 250.64M |
| Cibus | 250.50M |
| Tectonic Therapeutic | 250.48M |
| Delcath Systems | 245.63M |
| Senseonics Holdings | 244.63M |
| Gossamer Bio | 242.05M |